Genmab A/S

Genmab A/S Revenue per Share

The Revenue per Share of Genmab A/S (GMAB.CO) as of Nov 10, 2026 is 8.81 USD. In the previous year, Revenue per Share was 51.67 USD — a change of -82.95% (lower).

Revenue per Share

8.81USD

YoY

-82.95%

Last updated:

Revenue per Share of Genmab A/S is 2025 8.81 USD. Revenue per Share of Genmab A/S was 2024 51.67 USD. It decreases by -82.95% lower compared to the previous year.

The Genmab A/S Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2024
51.67 USD
Jan 1, 2025
8.81 USD
Jan 1, 2026 (e)
71.42 USD
Jan 1, 2027 (e)
86.28 USD
Jan 1, 2028 (e)
110.20 USD
Jan 1, 2029 (e)
123.95 USD
Jan 1, 2030 (e)
135.52 USD
Jan 1, 2031 (e)
108.21 USD
The Genmab A/S Revenue per Share history
YEARRevenue per ShareYoY
est108.21USD-20.15%
est135.52USD+9.33%
est123.95USD+12.48%
est110.20USD+27.73%
est86.28USD+20.81%
est71.42USD+710.60%
8.81USD-82.95%
51.67USD+35.16%
38.23USD+13.62%
33.65USD+68.98%
19.91USD-16.37%
23.81USD+85.24%
12.85USD+69.84%
7.57USD+31.56%
5.75USD+23.78%
4.65USD+57.48%
2.95USD+28.21%
2.30USD+20.74%
1.91USD+22.39%
1.56USD+29.91%
1.20USD-39.62%
1.99USD-0.67%
2.00USD+16.10%
1.72USD+30.74%
1.32USD+290.67%
0.34USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Revenue per Share of Genmab A/S is 8.81 USD in 2025.

Revenue per Share of Genmab A/S changed from 51.67 USD to 8.81 USD, representing a -82.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Genmab A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genmab A/S